Eing-Mei Tsai Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

2/2023	Phthalate derivative DEHP disturbs the antiproliferative effect of camptothecin in human lung cancer cells by attenuating DNA damage and activating Akt/NF-κB signaling pathway.
10/2018	Exogenous C₈-Ceramide Induces Apoptosis by Overproduction of ROS and the Switch of Superoxide Dismutases SOD1 to SOD2 in Human Lung Cancer Cells.
6/2017	A Quinone-Containing Compound Enhances Camptothecin-Induced Apoptosis of Lung Cancer Through Modulating Endogenous ROS and ERK Signaling.
2/2008	Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eing-Mei Tsai Research Topics

Disease

40	Neoplasms (Cancer) 06/2023 - 01/2003
37	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2007
17	Endometriosis 05/2023 - 01/2007
11	Neoplasm Metastasis (Metastasis) 02/2022 - 02/2011
10	Carcinogenesis 01/2019 - 08/2010
8	Body Weight (Weight, Body) 01/2020 - 11/2003
6	Inflammation (Inflammations) 12/2016 - 11/2005
5	Lung Neoplasms (Lung Cancer) 02/2023 - 02/2008
4	Triple Negative Breast Neoplasms 03/2024 - 03/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 02/2008
3	Adenomyosis 01/2021 - 04/2010
3	Adenocarcinoma 01/2019 - 02/2008
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 02/2010 - 01/2007
3	Stress Urinary Incontinence 08/2009 - 01/2008
3	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2007 - 07/2006
2	Carcinoma (Carcinomatosis) 05/2023 - 08/2021
2	Infections 12/2020 - 01/2007
2	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 12/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 06/2014
2	Gout 12/2016 - 10/2016
2	Necrosis 12/2016 - 01/2012
2	Hepatocellular Carcinoma (Hepatoma) 12/2015 - 08/2014
2	Parkinson Disease (Parkinson's Disease) 01/2015 - 01/2012
2	Leiomyoma (Uterine Fibroids) 12/2014 - 04/2010
2	Hypertension (High Blood Pressure) 08/2012 - 07/2011
1	Spontaneous Perforation 11/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 12/2020

Drug/Important Bio-Agent (IBA)

17	phthalic acid (phthalate)IBA 02/2023 - 04/2010
8	Hormones (Hormone)IBA 04/2024 - 01/2007
8	butylbenzyl phthalate (benzyl butyl phthalate)IBA 01/2021 - 01/2012
8	4-boronic acid benzophenoneIBA 01/2021 - 01/2012
7	Diethylhexyl Phthalate (DEHP)IBA 02/2023 - 02/2016
7	Estrogen ReceptorsIBA 01/2022 - 02/2012
6	MicroRNAs (MicroRNA)IBA 01/2019 - 02/2014
4	PlasticizersIBA 02/2023 - 08/2014
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2014
4	Biomarkers (Surrogate Marker)IBA 12/2020 - 09/2006
4	Interleukin-10 (Interleukin 10)IBA 12/2019 - 10/2009
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2023 - 06/2017
3	CamptothecinIBA 02/2023 - 06/2017
3	CytokinesIBA 02/2022 - 11/2005
3	mono-(2-ethylhexyl)phthalateIBA 01/2022 - 12/2014
3	Endocrine DisruptorsIBA 06/2021 - 01/2020
3	Estrogens (Estrogen)FDA Link 01/2021 - 02/2012
3	Tamoxifen FDA LinkGeneric 01/2021 - 02/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 09/2010
3	Nonmuscle Myosin Type IIAIBA 12/2016 - 06/2014
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2016 - 07/2012
3	Conditioned Culture MediaIBA 02/2016 - 06/2014
3	FlavonoidsIBA 02/2016 - 12/2010
3	EstersIBA 02/2016 - 02/2012
3	Dibutyl Phthalate (Butyl Phthalate)IBA 12/2014 - 02/2012
3	Small Interfering RNA (siRNA)IBA 01/2012 - 01/2012
2	Aurora Kinase AIBA 03/2024 - 11/2015
2	Environmental Pollutants (Pollutants, Environmental)IBA 02/2022 - 05/2016
2	2-methyl-5,6-cyclopentapyrimidineIBA 01/2022 - 11/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2015
2	CreatinineIBA 01/2022 - 12/2014
2	Tumor Biomarkers (Tumor Markers)IBA 12/2020 - 01/2015
2	Complementary DNA (cDNA)IBA 10/2020 - 01/2012
2	LigandsIBA 01/2020 - 02/2015
2	Formaldehyde (Formol)FDA Link 07/2019 - 01/2016
2	ParaffinIBA 07/2019 - 01/2016
2	CateninsIBA 04/2019 - 01/2016
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2019 - 08/2012
2	Metalloproteases (Metalloproteinases)IBA 11/2018 - 07/2015
2	Phytoestrogens (Phytoestrogen)IBA 01/2018 - 02/2014
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2017 - 12/2015
2	Topotecan (Hycamtin)FDA LinkGeneric 06/2017 - 12/2015
2	Phosphotransferases (Kinase)IBA 12/2016 - 12/2010
2	InterleukinsIBA 08/2014 - 10/2009
2	CarcinogensIBA 07/2012 - 08/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 02/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2011 - 10/2009
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 02/2010 - 02/2007
2	Nicotinamide PhosphoribosyltransferaseIBA 08/2007 - 07/2006
2	AdiponectinIBA 11/2006 - 01/2005
2	Atrial Natriuretic Factor (ANF)IBA 04/2005 - 11/2003
1	Valine (L-Valine)FDA Link 04/2024
1	Phenobarbital (Luminal)FDA Link 03/2024
1	LipidsIBA 06/2023
1	Acetyl-CoA CarboxylaseIBA 06/2023
1	Vorinostat FDA Link 05/2023
1	RNA (Ribonucleic Acid)IBA 09/2022
1	ORALIT (ORS)IBA 03/2022
1	EndoglinIBA 02/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022
1	venetoclaxIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	tariquidar (XR9576)IBA 06/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2021
1	CollagenIBA 01/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2012
7	Suburethral Slings (Tension-Free Vaginal Tape) 08/2012 - 09/2004
6	Drug Therapy (Chemotherapy) 03/2024 - 02/2008
3	Laparotomy 11/2023 - 01/2003
3	Intraperitoneal Injections 03/2016 - 11/2003
2	Hysterectomy 07/2011 - 01/2006
1	Nephroureterectomy 08/2021